Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetisk Diagnostik Vid medfödda Metabola Sjukdomar

NCT06376279 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.

NCT NCT06376279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06376279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetisk Diagnostik Vid medfödda Metabola Sjukdomar
Lead sponsor
Region Stockholm
Phase
Observational
Overall status
Enrolling by invitation
Start date
April 29, 2008
Completion date
December 31, 2030
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, epilepsy in children, lhon, metabolic disease, mitochondrial diseases, motor neuron disease